🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

5.977.099

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER ⓘ
—
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 1 día
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
15/06/2026 0,8200 USD
13/03/2026 0,8200 USD
15/12/2025 0,7900 USD
15/09/2025 0,7900 USD
13/06/2025 0,7900 USD
14/03/2025 0,7900 USD
13/12/2024 0,7700 USD
13/09/2024 0,7700 USD
14/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7500 USD
14/09/2023 0,7500 USD
14/06/2023 0,7500 USD
14/03/2023 0,7500 USD
14/12/2022 0,7300 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/07/2023 77,33 78,28 76,40 76,51 -0,88% 2,43% 6.258.600
26/07/2023 76,77 77,38 76,61 77,19 -0,05% 1,00% 4.049.700
25/07/2023 77,02 78,15 76,86 77,23 -0,55% 1,67% 5.298.400
24/07/2023 79,82 80,18 76,25 77,66 -3,70% 4,92% 11.333.500
21/07/2023 80,41 81,13 80,00 80,64 +0,88% 1,41% 14.984.400
20/07/2023 79,56 80,78 79,54 79,94 +1,24% 1,56% 6.046.000
19/07/2023 78,10 79,60 78,10 78,96 +0,95% 1,92% 5.351.600
18/07/2023 77,54 78,86 77,40 78,22 +0,96% 1,88% 5.244.900
17/07/2023 76,67 77,76 76,46 77,48 +0,38% 1,70% 4.954.600
14/07/2023 76,61 77,64 76,46 77,19 +0,63% 1,54% 6.072.300
13/07/2023 76,70 77,29 76,30 76,71 +0,43% 1,29% 3.341.700
12/07/2023 76,36 77,18 76,33 76,38 +0,34% 1,11% 5.185.100
11/07/2023 75,49 76,25 75,36 76,12 +0,57% 1,18% 3.529.800
10/07/2023 74,50 75,88 74,45 75,69 +1,71% 1,92% 5.554.900
07/07/2023 75,66 75,94 74,33 74,42 -2,39% 2,13% 6.550.700
06/07/2023 76,91 77,04 76,02 76,24 -1,29% 1,33% 5.020.300
05/07/2023 76,57 77,60 76,10 77,24 +0,68% 1,96% 5.308.300
03/07/2023 76,26 76,84 75,84 76,72 -0,45% 1,31% 3.437.300
30/06/2023 76,49 77,24 76,16 77,07 +1,39% 1,41% 6.017.200
29/06/2023 75,88 76,48 75,49 76,01 -0,22% 1,30% 5.295.800
28/06/2023 75,92 76,22 75,25 76,18 +0,22% 1,28% 4.486.900
27/06/2023 76,65 76,89 75,80 76,01 -0,72% 1,42% 5.111.200
26/06/2023 77,20 77,20 74,96 76,56 -1,17% 2,90% 6.106.200
23/06/2023 78,33 78,36 77,26 77,47 -0,82% 1,40% 4.815.500
22/06/2023 77,75 78,19 77,31 78,11 +0,64% 1,13% 3.408.800
21/06/2023 77,67 78,45 77,00 77,61 -0,13% 1,87% 5.342.300
20/06/2023 78,64 79,18 77,71 77,71 -1,46% 1,87% 5.410.000
16/06/2023 79,25 79,53 78,50 78,86 -0,18% 1,30% 13.982.700
15/06/2023 78,28 79,01 77,77 79,00 +1,35% 1,58% 6.526.200
14/06/2023 78,04 78,40 77,32 77,95 -0,64% 1,38% 6.069.400